The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Management of Cocaine Abuse and Dependence
Abstract
During the 20th century, there have been recurrent episodes of cocaine abuse in the United States that have achieved epidemic proportions.1 Although the total number of people using the drug has decreased in the past decade, cocaine-related biomedical and psychosocial problems remain a major public health problem in the United States and many other countries. The expanding list of cocaine-related toxic effects, acute and chronic, includes reproductive dysfunction, hepatic necrosis, and pulmonary disease.2 Abuse of and dependence on cocaine may also be associated with disorders of sexual function, sleep, anxiety, and mood, as well as with delirium and psychotic disorders. . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“We now have increasing evidence for postwithdrawal disorders with SSRI long-term use [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Data from controlled trials [15,20,29] , case reports [16] , and online patient reports [26] show that paroxetine is most likely to be associated with new withdrawal symptoms, and fluoxetine the least.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“According to most studies [1,15,16,20,29] , even with gradual tapering, withdrawal symptoms still occur.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Fava et al. [16] conducted a study of gradual SSRI discontinuation in panic disorder and found that 9 of 20 patients (45%) experienced new withdrawal symptoms, and that 3 of the 9 (33%) patients treated with paroxetine had postwithdrawal disorders at 1 year of follow-up, including bipolar spectrum disorder (n = 2) and major depressive disorder (n = 1).”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“They may resemble rebound symptoms being more severe than the original symptoms, but these disorders persist at least 6 weeks in contrast to rebound symptoms and [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Persistent postwithdrawal panic disorder [15,38] has been shown to occur following withdrawal of paroxetine, and paroxetine has also been associated with other postwithdrawal disorders [6,15,16] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,143
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 1,005
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Research works printed but not linked: 22
- Musto DF. The American disease: origins of narcotic control. New Haven, Conn.: Yale University Press, 1973.
- Mendelson JH, Mello NK. Cocaine and other commonly abused drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:2429-33.
- National Institute on Drug Abuse. Epidemiologic trends in drug abuse. Vol. 1. Highlights and executive summary. Washington, D.C.: Government Printing Office, 1995. (NIH publication no. 95-3988.)
- Johanson CE, 1989, Pharmacol Rev, 41, 3
- Foltin RW, 1991, J Pharmacol Exp Ther, 257, 247
- McCance EF, 1995, J Pharmacol Exp Ther, 274, 215
- Holman BL, 1991, J Nucl Med, 32, 1206
- Gawin FH, 1988, J Clin Psychiatry, 49, 11
- Millman R, 1988, J Clin Psychiatry, 49, 27
- Mendelson JH, 1992, J Pharmacol Exp Ther, 263, 505
- Mello NK, 1990, J Pharmacol Exp Ther, 254, 815
- Mello NK, 1993, J Pharmacol Exp Ther, 266, 804
- Covi L, 1994, Clin Pharmacol Ther, 55, 132
- Kosten TR, 1987, J Clin Psychiatry, 48, 442
- Kuhar MJ, 1993, Pharmacologist, 35, 28
- Kosten TR, 1988, Am J Psychiatry, 145, 381
- Preston KL, 1993, J Pharmacol Exp Ther, 267, 296
- Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1597-604.
- Mendelson JH, Albeck J. Naloxone modification of acute alcohol intoxication in humans. In: Proceedings of the 39th Annual Scientific Meeting, Committee on Problems of Drug Dependence, Cambridge, Mass, July 1977. Washington, D.C.: Committee on Problems of Drug Dependence, 1978:572-82.
- Mendelson JH, 1992, Neuropsychopharmacology, 7, 157
- Gastfriend DR, 1993, Am J Addict, 2, 269
- Gastfriend DR, Mendelson JH, Mello NK, et al. Longitudinal dose comparisons of buprenorphine for combined opiate and cocaine dependence. In: Harris LS, ed. Problems of drug dependence, 1995: proceedings of the 57th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph. Washington, D.C.: Government Printing Office (in press).
Cited by
Sorted by citations
Items 201–295 of 295
Marinho, E., Oliveira-Lima, A., Wuo-Silva, R., Santos, R., Baldaia, M., Hollais, A., Longo, B., Berro, L. F., & Frussa‐Filho, R. (2014) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001430 · Cited by 17
Ottaway, C. A., & Erickson, P. G. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00017-2 · Cited by 18
Metaxas, A., Keyworth, H. L., Yoo, J.-S., Chen, Y., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02023.x · Cited by 18
Stevenson, G. W., Wentland, M. P., Bidlack, J. M., Mello, N. K., & Negus, S. S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.051 · Cited by 18
Self-citationCross-reinstatement by cocaine and amphetamine of morphine-induced place preference in mice
Couto, B. R. D., Aguilar, M. A., Rodríguez‐Arias, M., & Miñarro, J. (2005) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000169183.83115.25 · Cited by 18
Mello, N. K. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00056-1 · Cited by 18
Self-citationButyrylcholinesterase: an enzyme antidote for cocaine intoxication
Mattes, C. E., Belendiuk, G., LYNCH, T. J., Brady, R. O., & Dretchen, K. L. (1998) · Addiction Biology · doi:10.1080/13556219872236 · Cited by 18
Rice, O. V., Heidbreder, C. A., Gardner, E. L., Schonhar, C. D., & Ashby, C. R. (2013) · Synapse · doi:10.1002/syn.21653 · Cited by 16
Hall, W., Doran, C. M., Degenhardt, L. J., & Shepard, D. S. (2006) · Europe PMC (PubMed Central) · Cited by 16
Effects of Luteinizing Hormone-Releasing Hormone on Plasma Cocaine Levels in Rhesus Monkeys
Mendelson, J. H., Mello, N. K., & Negus, S. S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38202-3 · Cited by 16
Self-citationCapsaicin, an active ingredient in pepper sprays, increases the lethality of cocaine
Mendelson, J. E., Tolliver, B. K., Delucchi, K., Baggott, M. J., Flower, K., Harris, C. W., Galloway, G. P., & Berger, P. A. (2009) · Forensic Toxicology · doi:10.1007/s11419-009-0079-9 · Cited by 15
Self-citationKohut, S. J., Fivel, P. A., Blough, B. E., Rothman, R. B., & Mello, N. K. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300059x · Cited by 15
Self-citationToward Cocaine Esterase Therapeutics
Rogers, C. J., Mee, J. M., Kaufmann, G. F., Dickerson, T. J., & Janda, K. D. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053086a · Cited by 15
Treatment of Cocaine Abuse in Methadone Maintenance Patients
Silverman, K., Bigelow, G. E., & Stitzer, M. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012347360-8/50017-3 · Cited by 14
Topiramate prevents ecstasy consumption: a case report
Akhondzadeh, S., & Hampa, A. D. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00355.x · Cited by 14
The efficiency of a carbamazepine–mianserin combination scheme in opiate detoxification
ZULLINO, D. F., Krenz, S., Favrat, B., Zimmermann, G., Bertschy, G., & Besson, J. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.610 · Cited by 14
Su, Z., Wenzel, J. M., Baird, R., & Ettenberg, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2088-0 · Cited by 13
Huang, X., Pan, Y., Zheng, F., & Zhan, C. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp106539w · Cited by 13
Zimmer, B. A., Chiodo, K. A., & Roberts, D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3305-4 · Cited by 15
KATP channels confer survival advantage in cocaine overdose
Reyes, S., Kane, G. C., Miki, T., Seino, S., & Terzic, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002083 · Cited by 13
Postoperative analgesia in patients with substance use disorders: Part I
Jage, J., & Bey, T. A. (2000) · Acute Pain · doi:10.1016/s1366-0071(00)80027-3 · Cited by 13
Huang, X., Zheng, F., & Zhan, C. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp2047807 · Cited by 12
Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men
Goletiani, N. V., Mendelson, J. H., Sholar, M. B., Siegel, A. J., & Mello, N. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.007 · Cited by 12
Self-citationThe dopamine D1 receptor agonist SKF-82958 serves as a discriminative stimulus in the rat
Haile, C. N., Carey, G. J., Varty, G. B., & Coffin, V. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00864-x · Cited by 12
Behavioral Pharmacology of Cocaine and the Determinants of Abuse Liability
Bergman, J., & Katz, J. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012347360-8/50005-7 · Cited by 12
Targeted Disruption of KATP Channels Aggravates Cardiac Toxicity in Cocaine Abuse
Reyes, S., Kane, G. C., Zingman, L. V., Yamada, S., & Terzic, A. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00145.x · Cited by 11
Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat
Cook, C. D., Carroll, I. F., & Beardsley, P. M. (2001) · Psychopharmacology · doi:10.1007/s002130100891 · Cited by 11
Current concepts in pharmacotherapy of substance abuse
Gottschalk, P., Jacobsen, L. K., & Kosten, T. R. (1999) · Current Psychiatry Reports · doi:10.1007/s11920-999-0028-7 · Cited by 11
Huang, X., Zhao, X., Zheng, F., & Zhan, C. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2111605 · Cited by 10
Use of Dopamine Agonist Pergolide in Outpatient Treatment of Cocaine Dependence
Focchi, G. R. D. A., Leite, M. C., de Andrade, A. G., & Scivoletto, S. (2005) · Substance Use & Misuse · doi:10.1081/ja-200030552 · Cited by 10
Impairments in reversal learning following short access to cocaine self-administration
Bechard, A. R., LaCrosse, A., Namba, M. D., Jackson, B., & Knackstedt, L. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.008 · Cited by 10
The rational use of drugs as therapeutic agents for the treatment of the alcoholisms
Wilcox, R. E., & McMillen, B. A. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00051-7 · Cited by 10
Kohut, S. J., DeCicco-Skinner, K. L., Johari, S., Hurwitz, Z. E., Baumann, M. H., & Riley, A. L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.012 · Cited by 8
Quednow, B. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00025-x · Cited by 11
SKF 38393 reverses cocaine-conditioned place preference in mice
Sabioni, P., D’Almeida, V., Andersen, M. L., Andreatini, R., & Galduróz, J. C. F. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.041 · Cited by 9
Bilodeau, J., & Schwendt, M. (2016) · Synapse · doi:10.1002/syn.21917 · Cited by 9
Carmo, G. P. D., Mello, N. K., Rice, K. C., Folk, J. E., & Negus, S. S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.075 · Cited by 9
Self-citationReducing short- and long-term cocaine craving with voluntary exercise in male rats
Carroll, M. E., Dougen, B., Zlebnik, N. E., Fess, L., & Smethells, J. R. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06251-0 · Cited by 8
Cui, J., Huang, N., Fan, G., Pan, T., Han, K., Jiang, C., Liu, X., Wang, F., Ma, L., & Le, Q. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02835-w · Cited by 8
Murthy, V., Reyes, S., Geng, L., Gao, Y., & Brimijoin, S. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228825 · Cited by 8
Toxin-Induced Coma and Central Nervous System Depression
Krause, M. A., & Hocker, S. E. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.07.002 · Cited by 8
Gao, D., Cho, H., Yang, W., Pan, Y., Yang, G., Tai, H., & Zhan, C. (2005) · Angewandte Chemie · doi:10.1002/ange.200503025 · Cited by 8
Desai, R. I., Neumeyer, J. L., Paronis, C. A., Nguyen, P., & Bergman, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.042 · Cited by 8
β_lactam antibiotics against drug addiction: A novel therapeutic option
Esmaili‐Shahzade‐Ali‐Akbari, P., Ghaderi, A., Hosseini, S. M. M., Nejat, F., Saeedi‐Mofrad, M., Houyeh, M. K., Ghattan, A., Etemadi, A., Rasoulian, E., & Khezri, A. (2023) · Drug Development Research · doi:10.1002/ddr.22110 · Cited by 7
Systemic injection of the DAD1 antagonist SCH 23390 reduces saccharin seeking in rats
Aoyama, K., Barnes, J., Koerber, J., Glueck, E., Dorsey, K., Eaton, L., & Grimm, J. W. (2016) · Appetite · doi:10.1016/j.appet.2016.05.008 · Cited by 7
Science, medicine, and the future: Substance use disorders
Schuckit, M. A. (1997) · BMJ · doi:10.1136/bmj.314.7094.1605 · Cited by 7
Helping patients who misuse drugs
(1997) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.1997.35318 · Cited by 7
Sanchez, L. R., Díaz-Morán, S., Grau‐López, L., Moreno, A. M. D., Eiroá‐Orosa, F. J., Roncero, C., Gonzalvo, B., Colom, J., & Casas, M. (2011) · PubMed · Cited by 6
Preclinical Evaluation of Pharmacotherapies for Cocaine Abuse
Winger, G. D. (1998) · Elsevier eBooks · doi:10.1016/b978-012347360-8/50008-2 · Cited by 6
Morelos-Santana, E., Islas-Preciado, D., Alcalá‐Lozano, R., Gonzalez-Olvera, J. J., & Estrada-Camarena, E. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-51901-2 · Cited by 6
Recent Advances for the Treatment of Cocaine Abuse: Central Nervous System Immunopharmacotherapy
Dickerson, T. J., & Janda, K. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-76678-2_14 · Cited by 5
Molecular and regional targets of cocaine in primate brain: liberation from prosaic views
Madras, B. K., Miller, G. M., Meltzer, P. C., Brownell, A., & Fischman, A. J. (2000) · Addiction Biology · doi:10.1111/j.1369-1600.2000.tb00202.x · Cited by 5
Treatment Populations, Services, and Outcomes for Cocaine and Crack-Cocaine Dependence
Johnson, R. A., & Gerstein, D. R. (2000) · Journal of Psychopathology and Behavioral Assessment · doi:10.1023/a:1007691723903 · Cited by 5
Zheng, F., Hou, S., Liu, X., Yang, W., & Zhan, C. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c06392 · Cited by 4
Hall, W., & Farrell, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.012 · Cited by 4
Novel monoamine transporter ligands reduce cocaine-induced enhancement of brain stimulation reward
Trzcińska, M., Pimentel, P., Stellar, J. R., Hanson, R. N., Choi, S.-W., Elmaleh, D. R., Zhang, J., Prakash, K. R. C., Tamiz, A. P., & Kozikowski, A. P. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00454-8 · Cited by 4
Oprisan, S. A., Clementsmith, X., Tompa, T., & Lavín, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223469 · Cited by 3
Medical complications of cocaine abuse
Shappell, C. M., Grieger, T. A., & Warden, D. L. (1997) · Medical Update for Psychiatrists · doi:10.1016/s1082-7579(97)00007-1 · Cited by 2
Pour démédicaliser la médecine des addictions
Jacques, J.-P. (2011) · Psychotropes · doi:10.3917/psyt.171.0123 · Cited by 2
The Patient with Substance Abuse Going to Surgery
Teperov, E. (2008) · Elsevier eBooks · doi:10.1016/b978-141602385-2.50016-0 · Cited by 1
Watson, R. W. (2006) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-56632-7_31 · Cited by 1
Kahn, E., Mikhael, H., & Vadivelu, N. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1951-2_12 · Cited by 1
Cocaine and Other Sympathomimetics
Rao, R. B., & Hoffman, R. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05472-0.00152-3 · Cited by 1
Azizzadeh, S., Rahimpour, M., Rakhshan, K., Makkiabadi, B., & Riahi, E. (2024) · Addiction Biology · doi:10.1111/adb.13442
Robinson, C. D. (2015) · Defense Technical Information Center (DTIC) · doi:10.21236/ad1012741 · Cited by 1
Abuso de alcohol y de sustancias
Karre, S., & Duke, J. (2006) · Elsevier eBooks · doi:10.1016/b978-84-8174-941-0.50051-3
Caputi, F. F. (2012) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/4558
Successful lung transplantation for heroin abstainer: A case report.
Xu, X., Chen, H., Wei, B., Dong, X., Yin, W., Wang, D., & He, J. (2011) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2011.01.07
Mechanisms mediating sex differences in the effects of cocaine
Zhao, W. (2008) · Deep Blue (University of Michigan)
Dickerson, T. J., & Janda, K. D. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9365-2
RetractedSteriotis, I. D., & Melanidis, I. (2002)
Sobie, J. L. (2007) · ScholarWorks - WMU (Western Michigan University)
Complicaciones medicas asociadas al consumo de cocaína
Puskovic, I. (2009) · Americanae (AECID Library)
Acute Cardiac Ischemia in Patients With Cocaine-Associated Complaints: Results of a
Feldman, J. A., Fish, S. S., Beshansky, J. R., Griffith, J. L., Woolard, R. H., & Selker, H. P. (2000)
Cocaine and Other Sympathomimetics
Schier, J. G., & Hoffman, R. S. (2005) · Elsevier eBooks · doi:10.1016/b978-0-323-01811-1.50067-5
Gil‐Miravet, I., Garrido, Z. T., Hernández, F. G., Gómez, A. P., & Salgado-Araujo, M. M. (2016) · Àgora de salut · doi:10.6035/agorasalut.2016.3.17
Critical Role of d -Serine Signaling in Synaptic Plasticity Relevant to Cocaine Addiction
D’Ascenzo, M., Mainardi, M., & Grassi, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803750-8.00016-6
Partydrugs en problematisch alcoholgebruik
Keeman, J. N., Mazel, J. A., & Zitman, F. G. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7785-5_5
Erb, S. M., & Placenza, F. M. (2010) · Neuromethods · doi:10.1007/978-1-60761-934-5_17
Schuckit, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3232-0_15
Marcus, E. M., Jacobson, S., & Sabin, T. D. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199744435.003.0027
Caine, S. B. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-045396-5.00076-2
Bird, J. (2013) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17003842
Rothman, R. B., & Baumann, M. H. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00182-7
Factors Underlying +/- 3, 4-Methylenedioxymethamphetamine Self Administration
Daniela, E. J. K. (2007) · doi:10.26686/wgtn.16926493.v1
The Role of Metabotropic Glutamate Receptor Subtype 5 in Mouse Models of Cocaine Addiction
Nicole, M., Briggs, L., Andrew, D., Brandon, G., & LaCrosse, A. (2023) · Addiction Research · doi:10.33425/2639-8451.1036
Dowson, M. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15654
Nwaneshiudu, C. A., Girdhar, K., Kleopoulos, S. P., Fullard, J. F., Butelman, E. R., Parvaz, M. A., Goldstein, R. Z., Nelly Alia-klein, A., & Roussos, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602908
BindingDB Entry 50008976: Pharmacotherapies for treatment of cocaine abuse: preclinical aspects.
BindingDB (2009) · UC San Diego · doi:10.7270/q2dn448n
Metadata
- Authors
- Mendelson, J. H., & Mello, N. K.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-04-11
- Volume
- 334
- Issue
- 15
- Pages
- 965-972
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338649220
- Cited by
- 291
- References
- 112
- Citations by year
- 2024: 4 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 20 · 2012: 14
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r18da006116-05)
- National Institute on Drug Abuse (DA 06116, K05DA000064, KO5-DA 00101, KO5 DA 00064, K05DA000101)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Youth, Drugs, and Violence
- Keywords
- cocaine abuse, cocaine dependence, cocaine toxicity, reproductive disorders, liver necrosis, lung disease, sexual dysfunction, sleep disorders, anxiety, mood disorders, delirium, psychosis
- MeSH terms
- Antidepressive Agents, Carbamazepine, Cocaine, Humans, Narcotic Antagonists, Narcotics, Dopamine Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review